Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a revised software version tag (Revision: v3.6.5), replacing the previous Revision: v3.6.4. This indicates a newer build of the site without altering the study information or displayed data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new site revision label appears: Revision: v3.6.4 replaces the previous v3.6.3 in the page footer. This indicates a minor platform update and does not affect the study information presented.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision indicator was updated to v3.6.3, replacing the previous v3.6.2. This signals a small update to the page's documentation/versioning without changing the study details or visible content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows a new revision label in the footer, indicating an update to the page version without altering the displayed study details or layout.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page adds sections for How to Read a Study Record, Common Questions, and How to Join a Study and presents recruitment status as 'No longer looking for participants,' while the Intervention/Treatment heading formatting is adjusted and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.9%

- Check67 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, indicating a backend or display update. It does not modify the study content or user-facing functionality beyond metadata.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.